Iisrael - heebrea - Ministry of Health

bioavenir ltd, israel - furosemide - תמיסה לאינפוזיה - furosemide 250 mg / 25 ml - furosemide - furosemide - for use only in treating patients with extremely reduced glomerular filtration.in acute renal insufficiency . in chronic renal insufficiency .oliguria in acute or chronic renal failure.

Iisrael - heebrea - Ministry of Health

bioavenir ltd - losartan as potassium 50 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin

Iisrael - heebrea - Ministry of Health

bioavenir ltd - losartan as potassium 100 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin

Iisrael - heebrea - Ministry of Health

bioavenir ltd - pravastatin sodium 40 mg - tablets - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *primary prevention of coronary events: in hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - reduce the risk of myocardial infarcton. - reduce the risk for revascularization. - reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *secondary prevention of cardiovascular events: atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: - slow the progression of coronary atherosclerosis. - reduce the risk of acute coronary events. myocardial infa

Iisrael - heebrea - Ministry of Health

bioavenir ltd, israel - aciclovir - אבקה להכנת תמיסה לאינפוזיה - aciclovir 250 mg - aciclovir - aciclovir - for the treatment of herpes simplex infections and severe intial genital herpes in the non immunocompromised. for the prophylaxis of herpes simplex infections in immune-compromised patients. in the treatment of varicella zoster infections. for herpes simplex encephalitis. for the treatment of herpes simplex infection in the neonate and infant up to 3 months of age.

Iisrael - heebrea - Ministry of Health

bioavenir ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 25 mg - sildenafil - sildenafil - treatment of erectile dysfunction.

Iisrael - heebrea - Ministry of Health

bioavenir ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 50 mg - sildenafil - sildenafil - treatment of erectile dysfunction.

Iisrael - heebrea - Ministry of Health

bioavenir ltd, israel - sildenafil as citrate - טבליות מצופות פילם - sildenafil as citrate 100 mg - sildenafil - sildenafil - treatment of erectile dysfunction.

Iisrael - heebrea - Ministry of Health

bioavenir ltd, israel - piperacillin as sodium salt; tazobactam as sodium salt - אבקה להכנת תמיסה לזריקה - tazobactam as sodium salt 500 mg; piperacillin as sodium salt 4000 mg - tazobactam - tazobactam - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms.tazo-pip avenir in combination with an aminoglycoside, is indicated for the treatment of suspected bacterial infections in neutropenic adults and children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Iisrael - heebrea - Ministry of Health

bioavenir ltd - cefuroxime as axetil 250 mg - film coated tablets - cefuroxime - treatment of infections caused by micro-organisms susceptible to cefuroxime.